About 1.4 kg more lean mass than the same resistance training without it.
Older adults (about 57 to 70 years) training 2 to 3 days a week.
Research-backed amino acid with potential health benefits. Helps your muscles produce more energy for short, intense efforts. Think lifting weights or sprinting. Also provides a backup energy source for your brain.
Source: Kreider et al. 2017 ISSN Position Stand
In the trial record, muscle creatine stores rise to a loaded level over about 4 weeks at 3 g daily, or about 1 week with a higher loading dose, and return toward baseline about 4 weeks after stopping.
Kept, not banked. The cited trial measured a return toward baseline after the last dose, so the effect holds while it is taken daily, not stored up. That rests on the trial window above.
Where a trial measured an actual number, we show it next to the claim. It is the average across the trials, never a promise about one person.
About 1.4 kg more lean mass than the same resistance training without it.
Older adults (about 57 to 70 years) training 2 to 3 days a week.
A small improvement in memory (standardized effect 0.29).
Healthy people, pooled across 8 randomised trials.
Read at the source. The magnitude sits beside the same trial the claim already cites. It describes what the trials measured, never what any one person will feel.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
The most studied ergogenic supplement, and the one with the strongest evidence. Meta-analyses across hundreds of trials show creatine monohydrate increases strength and lean mass alongside resistance training, at a maintained dose of 3 to 5 g a day.
About 1.4 kg more lean mass than the same resistance training without it.
Older adults (about 57 to 70 years) training 2 to 3 days a week. Confidence interval 1.0 to 1.8 kg.
A second line of research, outside the reason most people take this. It is held apart from the claims above and carries its own research strength.
A small improvement in memory (standardized effect 0.29).
Confidence interval 0.04 to 0.53.
Outcomes the engine found studied for these actives as a combination, not one at a time. Each is a finding a named trial measured, cited and dated, never written by the brand.
In a controlled trial in 24 men, taking creatine with a simple carbohydrate drink raised muscle total creatine about 60 percent more than creatine alone, and lowered the amount lost in urine.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Fail closed. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
Findings from trials that studied these actives as a combination. Context for how the actives were tested together, not a statement about any individual and not a claim about this product.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Creatine restocks the phosphocreatine that rapidly regenerates ATP during short, hard efforts, while beta-alanine raises muscle carnosine that buffers the acidity building up during longer high-intensity work. They support two different sides of muscular fatigue, which is why they are a long-standing pairing in performance formulas.
The creatine kinase reaction that passes a phosphate from phosphocreatine onto ADP to rebuild ATP works on the magnesium-bound forms of those nucleotides, so magnesium is a required cofactor for the very enzyme creatine acts through. Adequate magnesium supports the normal energy-transfer chemistry that creatine feeds into.
The body builds its own creatine using methyl groups, and betaine donates methyl groups that regenerate the methionine this pathway draws on, so the two sit on the same one-carbon metabolism. Both also act as cellular osmolytes that draw water into muscle cells.
Glycine is one of the two amino acids the body joins to build creatine, since AGAT combines arginine and glycine into guanidinoacetate. Glycine supply sits directly upstream of endogenous creatine formation.
Arginine donates the guanidino group that AGAT transfers onto glycine, the first step of creatine synthesis. The two share a single committed pathway.
The final step of creatine synthesis is a methyl transfer by GAMT, and SAM is the methyl donor it uses. Creatine formation is one of the largest single consumers of SAM in the body.
Choline oxidises to betaine, which re-methylates homocysteine back to methionine and so refills the SAM pool that GAMT draws on. Supplying methyl groups from choline eases the methylation load creatine synthesis creates.
B12-dependent methionine synthase regenerates methionine, and methionine becomes the SAM that methylates guanidinoacetate into creatine. Lower B12 status leaves less methyl capacity for that step.
Folate carries the one-carbon unit that methionine synthase hands to homocysteine, keeping the SAM pool that creatine synthesis spends topped up. Folate and creatine sit on the same methylation circuit.
Creatine enters muscle on CRT1 (SLC6A8), a sodium and chloride dependent transporter, so sodium availability is part of the uptake step. Both also raise intracellular water, which is why they appear together in loading formulas.
Taurine and creatine are both muscle osmolytes taken up by sodium-dependent SLC6 family transporters and both add to intracellular water. The shared transporter family means their uptake is related rather than independent.
Creatine transport into muscle is stimulated by insulin signalling, and alpha lipoic acid increases insulin sensitivity and glucose uptake in muscle. That makes it a carrier for creatine loading rather than an independent actor.
Caffeine has been reported to blunt the performance gain from creatine loading even when muscle creatine rose normally, and the two pull in opposite directions on muscle relaxation time and on fluid retention. Worth separating in time rather than combining blindly.
Creatine uptake into muscle runs through a sodium and chloride dependent transporter whose activity rises when insulin rises, so taking creatine with a protein and carbohydrate feed increases the fraction retained. The two supply different things: whey supplies amino acids for myofibrillar protein synthesis, creatine supplies phosphagen capacity for repeated high-intensity efforts. Trials of resistance training commonly give both together, which is why their effects are usually reported as a package rather than separately.
Endogenous creatine is built in two steps: arginine and glycine form guanidinoacetate, then guanidinoacetate N-methyltransferase adds a methyl group donated by S-adenosylmethionine. Methionine is the amino acid that regenerates S-adenosylmethionine, so methyl-group supply sits directly on the creatine synthesis route. Supplemental creatine reduces the draw on that pathway rather than adding to it, which is the mechanistic reason the two are discussed together.
Citrulline is converted to arginine in the kidney, and arginine is one of the two amino acids condensed into guanidinoacetate on the way to creatine. Supplementing creatine directly bypasses that route, so the pairing is about covering the arginine pool for other uses rather than making more creatine. In training formulas the two are combined for different targets: phosphagen capacity from creatine, nitric-oxide substrate from citrulline.
HMB is a leucine metabolite studied for its effect on muscle protein breakdown, while creatine acts on energy availability during repeated efforts. The targets differ, so a combined effect on training adaptation is plausible on mechanism. Combination evidence in humans is thinner than the evidence for either alone, so this is a formulation rationale rather than a demonstrated additive effect.
Leucine is the amino acid signal that initiates muscle protein synthesis through mTORC1, whereas creatine changes what the muscle can do in the session that provides the stimulus. One supplies the trigger, the other supplies the work capacity. Most human data come from whole-protein feeds containing leucine rather than isolated leucine plus creatine.
Phosphocreatine breakdown supports the first seconds of maximal effort; bicarbonate loading works on extracellular pH once glycolytic flux raises hydrogen ion load. Because the two buffer at different points on the same effort curve, they are studied together in repeated-sprint protocols. Bicarbonate at loading doses commonly causes gastrointestinal upset, which limits how the pair is used.
Dietary nitrate raises nitric oxide availability and has been reported to lower the oxygen cost of submaximal work, a different lever from the phosphagen system creatine loads. Combining them targets both the aerobic cost of exercise and the anaerobic ceiling. Human evidence for the combination specifically is limited, so this sits as an early rationale.
Ribose supplies the sugar backbone for adenine nucleotide resynthesis, while creatine buffers the ADP to ATP step through creatine kinase. Both sit in cellular energy handling but at different places, so the pairing is mechanistically coherent. Controlled human data on ribose plus creatine are sparse, and ribose alone has not shown consistent performance effects.
The creatine transporter is sodium dependent, so sodium status is part of how creatine gets into muscle. Creatine also acts as an intracellular osmolyte, which is why loading pulls water into muscle cells and raises total body water in the first week. Formulating with electrolytes reflects that shift in fluid distribution rather than any change in creatine itself.
Creatine loading increases intracellular water, and potassium is the main intracellular cation that travels with that compartment. The relationship is descriptive physiology, not a demonstrated performance interaction. It matters mostly for people whose potassium intake is already low while training in heat.
Coenzyme Q10 carries electrons in the respiratory chain that regenerates ATP, and creatine kinase shuttles that ATP as phosphocreatine between mitochondria and the myofibril. The two therefore sit on either side of the same energy transfer. Human combination trials are few, so the pairing is mechanistic rather than demonstrated.
Carnosine buffers hydrogen ions inside the muscle fibre, a different constraint from the phosphocreatine depletion that limits the earliest seconds of maximal work. Oral carnosine is largely hydrolysed to beta-alanine and histidine before it reaches muscle, which is why most research uses beta-alanine instead. On that basis the pairing is worth naming but the evidence base for intact carnosine is early.
Inositol and creatine are both organic osmolytes handled by sodium-dependent transporters, and cells adjust one osmolyte pool when another changes. That is why the two appear together in the literature with an antagonistic flag rather than a synergistic one. No human supplement data establish a meaningful interaction at intake levels people actually use.
Vitamin D receptors are expressed in skeletal muscle and low vitamin D status has been associated with lower measured strength, an association rather than a demonstrated cause. Creatine acts on energy supply within the fibre. The pairing is common in formulas for older adults doing resistance work, with combination evidence still early.
Nothing specific on file for Creatine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.Muscle can only hold so much, so a smaller daily amount keeps it topped up.
The body builds creatine from two amino acids plus a methyl group.
Creatine needs a specific carrier to get into muscle, and that carrier can be maxed out.
Supplementing raises a common blood marker for reasons that have nothing to do with how the kidney filters.
It is made in a factory from two simple chemicals, not taken out of meat, so the powder itself contains nothing animal derived.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Sarcosine (N-methylglycine) and cyanamide are the two industrial starting materials. Neither is animal derived, which is why supplement-grade creatine suits vegan formulations.
The two feedstocks are reacted in water under controlled pH and heat in a reactor, forming creatine, which then crystallises out as the monohydrate.
Repeated crystallisation and washing remove residual reactants and by-products, notably dicyandiamide and dihydrotriazine, which are the impurities specifications are written against.
Finished powder is assayed for creatine content and impurity limits, then milled to a defined mesh; micronised grades are simply milled finer for dispersion, not chemically different.
The commodity form is a white crystalline monohydrate powder, blended into powders or filled into capsules.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
Same mineral in different salts. Each is its own molecule with its own page, and absorption and feel differ from one to the next.
These are the studies our verdict leans on, chosen from the 3,356 we read for Creatine. The full linked list is below.
9 sources behind our Creatine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 2,452 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Creatine is, not how risky it is. A report is not proof Creatine caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.